Muira Puama (Ptychopetalum olacoides): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Muira Puama work in the body?

Muira Puama contains several active compounds including muirapuamine, beta-caryophyllene, alpha-copaene, and lupeol. These constituents are believed to support nervous system function and blood flow, which may explain its traditional use as a nerve tonic and aphrodisiac. Beta-caryophyllene has documented anti-inflammatory properties and may interact with cannabinoid receptors. However, the precise mechanism of action remains poorly understood, with evidence rated at Level C (preliminary clinical evidence). More research is needed to fully explain how Muira Puama exerts its effects on libido and cognitive function.

Does Muira Puama interact with any medications?

Muira Puama may interact with medications affecting blood pressure and the central nervous system. Because it can elevate blood pressure, it may reduce the effectiveness of antihypertensive drugs. Its stimulating properties could potentially interact with stimulants, antidepressants, or medications for anxiety and sleep disorders. Individuals taking heart medications should avoid Muira Puama due to potential cardiovascular effects. Always consult a healthcare provider before combining this herb with prescription medications, as formal interaction studies are limited.

What is the recommended dosage for Muira Puama?

The typical adult dosage of Muira Puama is 1-2 grams of dried bark or root daily. This can be prepared as a tea, decoction, tincture, or taken in capsule form. Standardized extracts may have different dosing based on concentration. Due to limited clinical evidence (Level C), there are no established therapeutic dosages from large-scale human trials. Traditional use suggests starting with lower doses to assess individual tolerance. Consult a qualified herbalist or healthcare provider for personalized dosing guidance.

Is Muira Puama safe during pregnancy and breastfeeding?

Muira Puama is considered unsafe during pregnancy and breastfeeding. The herb's stimulating properties and potential to elevate blood pressure pose risks to both maternal and fetal health. No clinical studies have evaluated its safety in pregnant or nursing women, and traditional use has not established a safety profile for these populations. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid Muira Puama entirely. Those with heart conditions should also avoid this herb.

What are the side effects of taking Muira Puama?

Reported side effects of Muira Puama include insomnia, anxiety, and elevated blood pressure. These effects are likely related to the herb's stimulating properties on the central nervous system. Some users may experience restlessness, increased heart rate, or difficulty sleeping, particularly when taken in high doses or close to bedtime. Individuals with pre-existing anxiety disorders, sleep conditions, or cardiovascular issues may be more susceptible to adverse effects. Discontinue use if significant side effects occur and consult a healthcare provider.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Muira Puama (Ptychopetalum olacoides) is a Brazilian medicinal plant used traditionally as a nerve tonic and sexual enhancer [PMID:12164265, PMID:15798997].

Background

Ptychopetalum olacoides is a folk medicinal plant primarily used for health care in Brazil [PMID:28750557].

Traditional uses

Amazonian peoples use traditional remedies prepared with P. olacoides roots to treat various age-related conditions [PMID:15507336, PMID:17023132], central nervous system conditions [PMID:12895682, PMID:17433649], and symptoms of lack of motivation and lassitude [PMID:19067380]. It is also used as a 'nerve tonic' [PMID:12164265].

Active compounds

Identified compounds include magnoflorine and menisperine (major constituents), N-trans-feruloyl-3,5-dihydroxyindolin-2-one, 4-coumaroylserotonin, moschamine, luteolin, 4'-methoxyluteolin, 3-methoxyluteolin, 3, 7-dimethoxyluteolin, caffeic acid, ferulic acid, vanillic acid, syringic acid, and ginsenoside Re [PMID:28750557]. Additionally, clerodane-type diterpenoids such as ptychonolide and ptycholides have been isolated from the bark [PMID:18821798, PMID:21485268].

Mechanism of action

P. olacoides ethanol extract (POEE) exhibits anticholinesterase activity by inhibiting acetylcholinesterase (AChE) in the rat frontal cortex, hippocampus, and striatum [PMID:12895682]. Its promnesic effects involve beta-adrenergic, dopamine D(1), and serotonin 5HT(2A) receptors [PMID:18561960]. In combination with other nutraceuticals (COMP-4), it stimulates the iNOS/NO-cGMP pathway, increasing nitric oxide (NO) and cGMP production in human and rat corporal smooth muscle cells and endothelial cells [PMID:29551532, PMID:34430391, PMID:39913351].

Clinical evidence

Evidence BFemale Sexual Dysfunction

A formulation of Muira puama and Ginkgo biloba (Herbal vX) showed significant improvements in frequency of sexual desires, intercourse, fantasies, and orgasmic intensity in 65% of a 202-woman sample [PMID:11186145]

Evidence CPeriocular Hyperpigmentation

A compound cream containing Pfaffia paniculata/Ptychopetalum olacoides B./Lilium candidum L. appeared to be a promising option with 90% improvement [PMID:23377386]

Evidence DCognitive Function (Animal Model)

POEE improved memory retrieval in both young and aging mice [PMID:15507336, PMID:17023132]

Evidence DErectile Dysfunction (Animal Model)

A combination (COMP-4) including muira puama reversed corporal smooth muscle loss and fibrosis in aging rats and improved erectile function [PMID:26405615, PMID:29551532]

Evidence DBone Fracture Healing (Animal Model)

The COMB-4 combination (including muira puama) resulted in 46% higher maximum strength and 92% higher stiffness in rat femoral osteotomy healing [PMID:28188129]

Evidence D

Safety & adverse effects

A clinical toxicology study of 'Catuama' (containing P. olacoides) in healthy volunteers reported no severe adverse reactions or haematological and biochemical changes over 28 days [PMID:15798997].

Evidence summary

Evidence is primarily based on animal models (D) and limited clinical observations (B/C). While promising for cognitive and sexual function, high-quality human RCTs are lacking.

PubMed sources

1.PMID: 22329652 (2012) — Ethnobotanical treatment strategies against Alzheimer's disease. · Current Alzheimer research
2.PMID: 10919969 (2000) — Selected herbals and human exercise performance. · The American journal of clinical nutrition
3.PMID: 33066617 (2020) — Pharmacology of Herbal Sexual Enhancers: A Review of Psychiatric and Neurological Adverse Effects. · Pharmaceuticals (Basel, Switzerland)
4.PMID: 28750557 (2018) — Qualitative and quantitative analysis of chemical constituents of Ptychopetalum olacoides Benth. · Natural product research
5.PMID: 15507336 (2004) — Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice. · Journal of ethnopharmacology

Muira Puama

Sources & Citations

Calculate a safe dose of Muira Puama